Advertisement
Canada markets close in 3 hours 50 minutes
  • S&P/TSX

    22,394.04
    +134.88 (+0.61%)
     
  • S&P 500

    5,200.99
    +13.32 (+0.26%)
     
  • DOW

    39,218.79
    +162.40 (+0.42%)
     
  • CAD/USD

    0.7307
    +0.0019 (+0.26%)
     
  • CRUDE OIL

    78.97
    -0.02 (-0.03%)
     
  • Bitcoin CAD

    85,404.84
    +356.64 (+0.42%)
     
  • CMC Crypto 200

    1,335.26
    +35.17 (+2.70%)
     
  • GOLD FUTURES

    2,337.40
    +15.10 (+0.65%)
     
  • RUSSELL 2000

    2,064.89
    +9.75 (+0.47%)
     
  • 10-Yr Bond

    4.4870
    -0.0050 (-0.11%)
     
  • NASDAQ

    16,326.38
    +23.62 (+0.14%)
     
  • VOLATILITY

    13.15
    +0.15 (+1.15%)
     
  • FTSE

    8,381.35
    +27.30 (+0.33%)
     
  • NIKKEI 225

    38,073.98
    -128.39 (-0.34%)
     
  • CAD/EUR

    0.6779
    +0.0003 (+0.04%)
     

Why Pot Stocks Canopy Growth, Sundial Growers, and Tilray All Had a Rough Week

Why Pot Stocks Canopy Growth, Sundial Growers, and Tilray All Had a Rough Week

Shares of Canopy Growth (NASDAQ: CGC), Sundial Growers (NASDAQ: SNDL), and Tilray (NASDAQ: TLRY) were all down by over 14% this week as of noon ET Friday, according to data from S&P Global Market Intelligence. In their latest earnings reports, for example, Canopy Growth and Sundial were both forced to write off millions in inventory due to sluggish sales and changing consumer trends. Canopy and Tilray are both banking heavily on the U.S. legalizing marijuana at the federal level soon.